Tadashi Matsumoto
Fondateur chez ReqMed Co., Ltd.
Postes actifs de Tadashi Matsumoto
Sociétés | Poste | Début | Fin |
---|---|---|---|
ReqMed Co., Ltd.
ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | 12/05/1998 | - | |
President | 12/05/1998 | - | |
Kihara Memorial Yokohama Foundation For The Advancement | Directeur/Membre du Conseil | 01/01/2010 | - |
Japan Ministry of Economy, Trade & Industry | Corporate Officer/Principal | 01/01/2009 | - |
Historique de carrière de Tadashi Matsumoto
Anciens postes connus de Tadashi Matsumoto
Sociétés | Poste | Début | Fin |
---|---|---|---|
TELLA, INC. | Directeur/Membre du Conseil | 01/03/2017 | 27/03/2019 |
ReqMed Research, Inc. | Directeur Général | 01/01/1999 | - |
Formation de Tadashi Matsumoto
University of Tokyo | Undergraduate Degree |
University of Tsukuba | Masters Business Admin |
Statistiques
Internationale
Japon | 7 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Japan Ministry of Economy, Trade & Industry | Government |
ReqMed Co., Ltd.
ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Health Technology |
ReqMed Research, Inc. | |
Kihara Memorial Yokohama Foundation For The Advancement | |
tella, Inc.
tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Tadashi Matsumoto
- Expérience